Skip to content

Clinical trials

Completed Cholangiocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Status: Completed Clear all

226 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20032
20043
20051
20063
20072
20086
20097
20105
20117
201210
201315
201412
201511
201613
201719
201824
201917
202020
202116
202212
20237
20248
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed226

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
Memorial Sloan Kettering Cancer Center5
First People's Hospital of Hangzhou4
Peking Union Medical College Hospital4
Washington University School of Medicine4
Celldex Therapeutics3
City of Hope Medical Center3
Massachusetts General Hospital3
Mayo Clinic3
Merck Sharp & Dohme LLC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma226
Pancreatic Neoplasms40
Gallbladder Neoplasms38
Carcinoma, Hepatocellular36
Biliary Tract Neoplasms30
Liver Neoplasms29
Stomach Neoplasms28
Bile Duct Neoplasms23
Colorectal Neoplasms22
Ovarian Neoplasms19

Trials

Showing 1 to 25 of 226. Each trial links to its page on Pharma Observatory.

126 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.